Diabetes . Risk of coronary artery disease, heart failure and atrial fibrillation

被引:0
作者
Stratmann, B. [1 ]
Hertrampf, K. [1 ,2 ]
Tschoepe, D. [1 ,2 ]
机构
[1] Ruhr Univ Bochum, Herz & Diabet Zentrum NRW, D-32545 Bad Oeynhausen, Germany
[2] Deutsch Diabet Stiftung, Stiftung Der Herzkranke Diabetiker DHD, Berlin, Germany
来源
DIABETOLOGE | 2013年 / 9卷 / 02期
关键词
HbA(1c); Mortality; Myocardial revascularization; Diabetic cardiomyopathies; Ventricular remodeling; EUROPEAN-SOCIETY; TASK-FORCE; TYPE-2; REVASCULARIZATION; CARDIOMYOPATHY; ASSOCIATION; GUIDELINES; MELLITUS;
D O I
10.1007/s11428-012-0993-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus is a well-known risk factor for the development of coronary artery disease. The close relationship between metabolic disorders in terms of prediabetes (impaired fasting glucose and impaired glucose tolerance) and heart failure as well as atrial fibrillation is comparable new but not only is diabetes associated with heart diseases the reverse is also true that the diagnosis of diabetes is often made in patients with heart disease. This interplay between metabolism and heart disease needs to be taken into account for diagnostics and therapeutic interventions so that the diabetic heart patient can be treated adequately. A prominent gender-specific effect is described in this scenario which is even more pronounced in this patient cohort suffering from diabetes and heart disease. The main topic of this article is to demonstrate the interrelation and the resulting treatment schedules of these diseases.
引用
收藏
页码:157 / 165
页数:9
相关论文
共 50 条
[41]   Anticoagulant therapy for chronic cardiac diseases. Atrial fibrillation, valvular heart disease, congestive heart failure [J].
Witzenbichler, B. .
INTERNIST, 2011, 52 (11) :1301-+
[42]   Gamma-glutamyl transferase and atrial fibrillation in patients with coronary artery disease [J].
Ndrepepa, Gjin ;
Xhepa, Erion ;
Colleran, Roisin ;
Braun, Siegmund ;
Cassese, Salvatore ;
Fusaro, Massimiliano ;
Laugwitz, Karl-Ludwig ;
Kastrati, Adnan .
CLINICA CHIMICA ACTA, 2017, 465 :17-21
[43]   Diabetes mellitus, coronary artery disease and heart disease [J].
Clodi, Martin ;
Saely, Christoph ;
Hoppichler, Friedrich ;
Resl, Michael ;
Steinwender, Clemens ;
Eber, Bernd .
WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 :S212-S215
[44]   Diabetes is a predictor of coronary artery stenosis in patients hospitalized with heart failure [J].
Kosuga, Tsuneharu ;
Komukai, Kimiaki ;
Miyanaga, Satoru ;
Kubota, Takeyuki ;
Nakata, Kotaro ;
Suzuki, Kenichiro ;
Yamada, Takayuki ;
Yoshida, Jun ;
Kimura, Haruka ;
Yoshimura, Michihiro .
HEART AND VESSELS, 2016, 31 (05) :671-676
[45]   Update on revascularization in patients with heart failure and coronary artery disease [J].
Hage, Fadi ;
Hage, Ali ;
Haddad, Haissam ;
Kiaii, Bob .
CURRENT OPINION IN CARDIOLOGY, 2018, 33 (02) :232-236
[46]   Patients with atrial fibrillation and coronary artery disease - Double trouble [J].
Michniewicz, Ewelina ;
Mlodawska, Elzbieta ;
Lopatowska, Paulina ;
Tomaszuk-Kazberuk, Anna ;
Malyszko, Jolanta .
ADVANCES IN MEDICAL SCIENCES, 2018, 63 (01) :30-35
[47]   Obesity Management for Patients with Coronary Artery Disease and Heart Failure [J].
Syed, AkheelA. ;
Adam, Safwaan ;
Miller, Christopher A. ;
Alkhaffaf, Bilal .
HEART FAILURE CLINICS, 2025, 21 (02) :257-271
[48]   Atrial fibrillation in heart failure is associated with an increased risk of death only in patients with ischaemic heart disease [J].
Raunso, Jakob ;
Pedersen, Ole Dyg ;
Dominguez, Helena ;
Hansen, Morten Lock ;
Moller, Jacob Eifer ;
Kjaergaard, Jesper ;
Hassager, Christian ;
Torp-Pedersen, Christian ;
Kober, Lars .
EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (07) :692-697
[49]   Atrial Fibrillation in Heart Failure [J].
Lardizabal, Joel A. ;
Deedwania, Prakash C. .
MEDICAL CLINICS OF NORTH AMERICA, 2012, 96 (05) :987-+
[50]   Combined management of atrial fibrillation and heart failure: case studies [J].
Verbrugge, Frederik H. ;
Mullens, Wilfried .
HEART FAILURE REVIEWS, 2014, 19 (03) :331-339